# Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

> **NCT00262327** · PHASE1 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 20 (—)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Antangiogenesis
- **GENETIC:** endostatin gene

## Key facts

- **NCT ID:** NCT00262327
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262327, "Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00262327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*